Your browser doesn't support javascript.
loading
Clinical and Phenotypic Characterization of Common Variable Immunodeficiency Diagnosed in Younger and Older Adults.
Fortier, Julia C; Haltigan, Emily; Cavero-Chavez, Vanessa; Gomez-Manjarres, Diana; Squire, Jacqueline D; Reeves, Westley H; Cuervo-Pardo, Lyda.
Afiliação
  • Fortier JC; University of Florida College of Medicine, Gainesville, FL, USA.
  • Haltigan E; Department of Medicine, University of Florida, Gainesville, FL, USA.
  • Cavero-Chavez V; Department of Pediatrics, Division of Rheumatology, Allergy & Clinical Immunology, University of Florida, Gainesville, FL, USA.
  • Gomez-Manjarres D; Department of Medicine, Division of Pulmonary, Critical Care & Sleep, University of Florida, Gainesville, FL, USA.
  • Squire JD; Department of Medicine, Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Reeves WH; Department of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, FL, USA.
  • Cuervo-Pardo L; Department of Medicine, Division of Rheumatology, Allergy & Clinical Immunology, University of Florida, Gainesville, FL, USA.
J Clin Immunol ; 42(6): 1270-1279, 2022 08.
Article em En | MEDLINE | ID: mdl-35588029
ABSTRACT

PURPOSE:

Common variable immunodeficiency (CVID) is the most prevalent symptomatic immunodeficiency in adults. Little is known about the manifestations of CVID presenting in older adults. Herein, we performed a phenotypic characterization of patients diagnosed older than age 40.

METHODS:

A retrospective chart review of 79 patients seen at UF Health between 2006 and 2020 with a verified diagnosis of CVID per the ICON 2016 criteria was conducted. Patients were classified according to four phenotypes no-disease-related complications, autoimmune cytopenias, polyclonal lymphoproliferation, and unexplained enteropathy. Patients diagnosed with CVID from age 2 to 40 (n = 41, "younger cohort") were compared to patients diagnosed with CVID age 41 and older (n = 38, "older cohort").

RESULTS:

Among the younger cohort, pathologic genetic variants, positive family history for immunodeficiency, autoimmunity (49% vs 24%, p = 0.03), and splenomegaly (46% vs 16%, p = 0.004) were more common, as was the "autoimmune cytopenias" phenotype (24% vs 3%, p = 0.007). Among the older cohort, lymphoma (11% vs 0%, p = 0.049) and the "no disease-related complications" phenotype (79% vs 57%, p = 0.03) were more commonly seen. Comorbidities such as bronchiectasis (27% vs 21%, p = 0.61), GI involvement (34% vs 24%, p = 0.33), and GLILD (5% vs 8%, p = 0.67) were equally present among both the younger and older cohorts, respectively.

CONCLUSION:

The lower incidence of autoimmunity and splenomegaly, as well as overlapping clinical features with immunosenescence, may make diagnosing CVID in older patients more challenging; however, the disease is not more indolent as the risks for lymphoma, bronchiectasis, and GLILD are similar to those of younger patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiectasia / Imunodeficiência de Variável Comum / Leucopenia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiectasia / Imunodeficiência de Variável Comum / Leucopenia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article